临床试验

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

NCT：NCT06965504 · NOT_YET_RECRUITING

NCT编号NCT06965504

状态NOT_YET_RECRUITING

开始日期2026-09-01

完成时间2029-06-01

SponsorAbiomed Inc. (INDUSTRY)

First posted2025-05-11

Last updated2026-09-10

简要摘要

The study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in patients with decompensated heart failure and cardiogenic shock.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。